Skip to Main Content

Lineage Cell Therapeutics

Lineage Cell Therapeutics develops allogeneic cell therapies, including OpRegen® for age-related macular degeneration and OPC1 for spinal cord injuries, using a proprietary platform to create specialized human cells.

Specifications
Lineage-Cell-Therapeutics Homepage 1440px